FEBS LETTERS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204388, encodeId=6063220438899, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因编辑 经验分享：4.11投稿，12号通过主编审核，送了外审，显示under review。但现在已经1个月了，一直是under review没消息，服了，想问一下，发邮件催稿对审核结果有没有影响啊，想催但是有点不太敢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:18:07 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204389, encodeId=05b02204389f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因编辑 经验分享：4.11号投稿，12号通过主编审核，送外审，显示的under review，但是已经一个月过去了，，没有外审结果。想问一下催稿会影响审稿结果吗，想催但是又不太敢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:24:04 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2160762, encodeId=bc282160e6295, content=当天秒拒！这么高效的杂志竟然还有点冷门，不应该呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI64l0IicibOfsgqfemdpq8fT5wO32W4WBX7MPfmT5IxVSOwwzOichZIlM0nkOCWzZSs2m9cQ5DcibIiaQ/132, createdBy=d7af2250612, createdName=viviaya, createdTime=Tue Oct 03 17:58:43 CST 2023, time=2023-10-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1182993, encodeId=9a5711829937b, content=各位大神，这个杂志是收短的letter还是普通的article？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLavbJ2R1TmjvPODue2WrnIQnlfz5hB04sROM546B9oLHvY58gSm21nA1K8ZdK0icGmZoibic26aC33w/0, createdBy=500b2173298, createdName=ms776015483565643, createdTime=Mon Jan 10 22:35:29 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181961, encodeId=58a9118196150, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理学 经验分享：很快，两天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Jan 07 19:57:39 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=)]

2019-02-09 124a44c5m26暂无昵称

审稿速度:1.0 | 投稿命中率:25.0
经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试

224 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204388, encodeId=6063220438899, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因编辑 经验分享：4.11投稿，12号通过主编审核，送了外审，显示under review。但现在已经1个月了，一直是under review没消息，服了，想问一下，发邮件催稿对审核结果有没有影响啊，想催但是有点不太敢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:18:07 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204389, encodeId=05b02204389f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因编辑 经验分享：4.11号投稿，12号通过主编审核，送外审，显示的under review，但是已经一个月过去了，，没有外审结果。想问一下催稿会影响审稿结果吗，想催但是又不太敢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:24:04 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2160762, encodeId=bc282160e6295, content=当天秒拒！这么高效的杂志竟然还有点冷门，不应该呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI64l0IicibOfsgqfemdpq8fT5wO32W4WBX7MPfmT5IxVSOwwzOichZIlM0nkOCWzZSs2m9cQ5DcibIiaQ/132, createdBy=d7af2250612, createdName=viviaya, createdTime=Tue Oct 03 17:58:43 CST 2023, time=2023-10-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1182993, encodeId=9a5711829937b, content=各位大神，这个杂志是收短的letter还是普通的article？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLavbJ2R1TmjvPODue2WrnIQnlfz5hB04sROM546B9oLHvY58gSm21nA1K8ZdK0icGmZoibic26aC33w/0, createdBy=500b2173298, createdName=ms776015483565643, createdTime=Mon Jan 10 22:35:29 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181961, encodeId=58a9118196150, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理学 经验分享：很快，两天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Jan 07 19:57:39 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=)]

2018-09-28 shicongdemao

请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表::
周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表:
周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖

xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖

297 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204388, encodeId=6063220438899, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因编辑 经验分享：4.11投稿，12号通过主编审核，送了外审，显示under review。但现在已经1个月了，一直是under review没消息，服了，想问一下，发邮件催稿对审核结果有没有影响啊，想催但是有点不太敢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:18:07 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204389, encodeId=05b02204389f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因编辑 经验分享：4.11号投稿，12号通过主编审核，送外审，显示的under review，但是已经一个月过去了，，没有外审结果。想问一下催稿会影响审稿结果吗，想催但是又不太敢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:24:04 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2160762, encodeId=bc282160e6295, content=当天秒拒！这么高效的杂志竟然还有点冷门，不应该呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI64l0IicibOfsgqfemdpq8fT5wO32W4WBX7MPfmT5IxVSOwwzOichZIlM0nkOCWzZSs2m9cQ5DcibIiaQ/132, createdBy=d7af2250612, createdName=viviaya, createdTime=Tue Oct 03 17:58:43 CST 2023, time=2023-10-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1182993, encodeId=9a5711829937b, content=各位大神，这个杂志是收短的letter还是普通的article？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLavbJ2R1TmjvPODue2WrnIQnlfz5hB04sROM546B9oLHvY58gSm21nA1K8ZdK0icGmZoibic26aC33w/0, createdBy=500b2173298, createdName=ms776015483565643, createdTime=Mon Jan 10 22:35:29 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181961, encodeId=58a9118196150, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理学 经验分享：很快，两天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Jan 07 19:57:39 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=)]

2021-01-13 ms1000001697547505

一周了还在undeegoing initial checking，有朋友是这种情况吗

87 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204388, encodeId=6063220438899, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因编辑 经验分享：4.11投稿，12号通过主编审核，送了外审，显示under review。但现在已经1个月了，一直是under review没消息，服了，想问一下，发邮件催稿对审核结果有没有影响啊，想催但是有点不太敢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:18:07 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204389, encodeId=05b02204389f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因编辑 经验分享：4.11号投稿，12号通过主编审核，送外审，显示的under review，但是已经一个月过去了，，没有外审结果。想问一下催稿会影响审稿结果吗，想催但是又不太敢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:24:04 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2160762, encodeId=bc282160e6295, content=当天秒拒！这么高效的杂志竟然还有点冷门，不应该呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI64l0IicibOfsgqfemdpq8fT5wO32W4WBX7MPfmT5IxVSOwwzOichZIlM0nkOCWzZSs2m9cQ5DcibIiaQ/132, createdBy=d7af2250612, createdName=viviaya, createdTime=Tue Oct 03 17:58:43 CST 2023, time=2023-10-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1182993, encodeId=9a5711829937b, content=各位大神，这个杂志是收短的letter还是普通的article？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLavbJ2R1TmjvPODue2WrnIQnlfz5hB04sROM546B9oLHvY58gSm21nA1K8ZdK0icGmZoibic26aC33w/0, createdBy=500b2173298, createdName=ms776015483565643, createdTime=Mon Jan 10 22:35:29 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181961, encodeId=58a9118196150, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理学 经验分享：很快，两天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Jan 07 19:57:39 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=)]

2024-05-13 ms1000001582476997 来自湖北省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：基因编辑
经验分享：4.11投稿，12号通过主编审核，送了外审，显示under review。但现在已经1个月了，一直是under review没消息，服了，想问一下，发邮件催稿对审核结果有没有影响啊，想催但是有点不太敢。。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204388, encodeId=6063220438899, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因编辑 经验分享：4.11投稿，12号通过主编审核，送了外审，显示under review。但现在已经1个月了，一直是under review没消息，服了，想问一下，发邮件催稿对审核结果有没有影响啊，想催但是有点不太敢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:18:07 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204389, encodeId=05b02204389f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因编辑 经验分享：4.11号投稿，12号通过主编审核，送外审，显示的under review，但是已经一个月过去了，，没有外审结果。想问一下催稿会影响审稿结果吗，想催但是又不太敢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:24:04 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2160762, encodeId=bc282160e6295, content=当天秒拒！这么高效的杂志竟然还有点冷门，不应该呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI64l0IicibOfsgqfemdpq8fT5wO32W4WBX7MPfmT5IxVSOwwzOichZIlM0nkOCWzZSs2m9cQ5DcibIiaQ/132, createdBy=d7af2250612, createdName=viviaya, createdTime=Tue Oct 03 17:58:43 CST 2023, time=2023-10-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1182993, encodeId=9a5711829937b, content=各位大神，这个杂志是收短的letter还是普通的article？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLavbJ2R1TmjvPODue2WrnIQnlfz5hB04sROM546B9oLHvY58gSm21nA1K8ZdK0icGmZoibic26aC33w/0, createdBy=500b2173298, createdName=ms776015483565643, createdTime=Mon Jan 10 22:35:29 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181961, encodeId=58a9118196150, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理学 经验分享：很快，两天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Jan 07 19:57:39 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=)]

2024-05-13 ms1000001582476997 来自湖北省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：基因编辑
经验分享：4.11号投稿，12号通过主编审核，送外审，显示的under review，但是已经一个月过去了，，没有外审结果。想问一下催稿会影响审稿结果吗，想催但是又不太敢#期刊论坛#

2 0

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204388, encodeId=6063220438899, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因编辑 经验分享：4.11投稿，12号通过主编审核，送了外审，显示under review。但现在已经1个月了，一直是under review没消息，服了，想问一下，发邮件催稿对审核结果有没有影响啊，想催但是有点不太敢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:18:07 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204389, encodeId=05b02204389f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因编辑 经验分享：4.11号投稿，12号通过主编审核，送外审，显示的under review，但是已经一个月过去了，，没有外审结果。想问一下催稿会影响审稿结果吗，想催但是又不太敢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:24:04 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2160762, encodeId=bc282160e6295, content=当天秒拒！这么高效的杂志竟然还有点冷门，不应该呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI64l0IicibOfsgqfemdpq8fT5wO32W4WBX7MPfmT5IxVSOwwzOichZIlM0nkOCWzZSs2m9cQ5DcibIiaQ/132, createdBy=d7af2250612, createdName=viviaya, createdTime=Tue Oct 03 17:58:43 CST 2023, time=2023-10-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1182993, encodeId=9a5711829937b, content=各位大神，这个杂志是收短的letter还是普通的article？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLavbJ2R1TmjvPODue2WrnIQnlfz5hB04sROM546B9oLHvY58gSm21nA1K8ZdK0icGmZoibic26aC33w/0, createdBy=500b2173298, createdName=ms776015483565643, createdTime=Mon Jan 10 22:35:29 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181961, encodeId=58a9118196150, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理学 经验分享：很快，两天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Jan 07 19:57:39 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=)]

2023-10-03 viviaya 来自重庆

当天秒拒！这么高效的杂志竟然还有点冷门，不应该呀

31 0

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204388, encodeId=6063220438899, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因编辑 经验分享：4.11投稿，12号通过主编审核，送了外审，显示under review。但现在已经1个月了，一直是under review没消息，服了，想问一下，发邮件催稿对审核结果有没有影响啊，想催但是有点不太敢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:18:07 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204389, encodeId=05b02204389f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因编辑 经验分享：4.11号投稿，12号通过主编审核，送外审，显示的under review，但是已经一个月过去了，，没有外审结果。想问一下催稿会影响审稿结果吗，想催但是又不太敢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:24:04 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2160762, encodeId=bc282160e6295, content=当天秒拒！这么高效的杂志竟然还有点冷门，不应该呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI64l0IicibOfsgqfemdpq8fT5wO32W4WBX7MPfmT5IxVSOwwzOichZIlM0nkOCWzZSs2m9cQ5DcibIiaQ/132, createdBy=d7af2250612, createdName=viviaya, createdTime=Tue Oct 03 17:58:43 CST 2023, time=2023-10-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1182993, encodeId=9a5711829937b, content=各位大神，这个杂志是收短的letter还是普通的article？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLavbJ2R1TmjvPODue2WrnIQnlfz5hB04sROM546B9oLHvY58gSm21nA1K8ZdK0icGmZoibic26aC33w/0, createdBy=500b2173298, createdName=ms776015483565643, createdTime=Mon Jan 10 22:35:29 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181961, encodeId=58a9118196150, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理学 经验分享：很快，两天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Jan 07 19:57:39 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=)]

2022-01-10 ms776015483565643

各位大神，这个杂志是收短的letter还是普通的article？

54 0

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204388, encodeId=6063220438899, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因编辑 经验分享：4.11投稿，12号通过主编审核，送了外审，显示under review。但现在已经1个月了，一直是under review没消息，服了，想问一下，发邮件催稿对审核结果有没有影响啊，想催但是有点不太敢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:18:07 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204389, encodeId=05b02204389f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因编辑 经验分享：4.11号投稿，12号通过主编审核，送外审，显示的under review，但是已经一个月过去了，，没有外审结果。想问一下催稿会影响审稿结果吗，想催但是又不太敢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:24:04 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2160762, encodeId=bc282160e6295, content=当天秒拒！这么高效的杂志竟然还有点冷门，不应该呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI64l0IicibOfsgqfemdpq8fT5wO32W4WBX7MPfmT5IxVSOwwzOichZIlM0nkOCWzZSs2m9cQ5DcibIiaQ/132, createdBy=d7af2250612, createdName=viviaya, createdTime=Tue Oct 03 17:58:43 CST 2023, time=2023-10-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1182993, encodeId=9a5711829937b, content=各位大神，这个杂志是收短的letter还是普通的article？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLavbJ2R1TmjvPODue2WrnIQnlfz5hB04sROM546B9oLHvY58gSm21nA1K8ZdK0icGmZoibic26aC33w/0, createdBy=500b2173298, createdName=ms776015483565643, createdTime=Mon Jan 10 22:35:29 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181961, encodeId=58a9118196150, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理学 经验分享：很快，两天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Jan 07 19:57:39 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=)]

2022-01-07 第五先生

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：药理学
经验分享：很快，两天秒拒

55 0

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204388, encodeId=6063220438899, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因编辑 经验分享：4.11投稿，12号通过主编审核，送了外审，显示under review。但现在已经1个月了，一直是under review没消息，服了，想问一下，发邮件催稿对审核结果有没有影响啊，想催但是有点不太敢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:18:07 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204389, encodeId=05b02204389f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因编辑 经验分享：4.11号投稿，12号通过主编审核，送外审，显示的under review，但是已经一个月过去了，，没有外审结果。想问一下催稿会影响审稿结果吗，想催但是又不太敢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:24:04 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2160762, encodeId=bc282160e6295, content=当天秒拒！这么高效的杂志竟然还有点冷门，不应该呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI64l0IicibOfsgqfemdpq8fT5wO32W4WBX7MPfmT5IxVSOwwzOichZIlM0nkOCWzZSs2m9cQ5DcibIiaQ/132, createdBy=d7af2250612, createdName=viviaya, createdTime=Tue Oct 03 17:58:43 CST 2023, time=2023-10-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1182993, encodeId=9a5711829937b, content=各位大神，这个杂志是收短的letter还是普通的article？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLavbJ2R1TmjvPODue2WrnIQnlfz5hB04sROM546B9oLHvY58gSm21nA1K8ZdK0icGmZoibic26aC33w/0, createdBy=500b2173298, createdName=ms776015483565643, createdTime=Mon Jan 10 22:35:29 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181961, encodeId=58a9118196150, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理学 经验分享：很快，两天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Jan 07 19:57:39 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=)]

2021-07-31 ms2000000005051387

偏重的研究方向：药理学
经验分享：请问各位大神药理学方向可以投吗？

78 0

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204388, encodeId=6063220438899, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：基因编辑 经验分享：4.11投稿，12号通过主编审核，送了外审，显示under review。但现在已经1个月了，一直是under review没消息，服了，想问一下，发邮件催稿对审核结果有没有影响啊，想催但是有点不太敢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:18:07 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204389, encodeId=05b02204389f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因编辑 经验分享：4.11号投稿，12号通过主编审核，送外审，显示的under review，但是已经一个月过去了，，没有外审结果。想问一下催稿会影响审稿结果吗，想催但是又不太敢<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e149079992, createdName=ms1000001582476997, createdTime=Mon May 13 11:24:04 CST 2024, time=2024-05-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2160762, encodeId=bc282160e6295, content=当天秒拒！这么高效的杂志竟然还有点冷门，不应该呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI64l0IicibOfsgqfemdpq8fT5wO32W4WBX7MPfmT5IxVSOwwzOichZIlM0nkOCWzZSs2m9cQ5DcibIiaQ/132, createdBy=d7af2250612, createdName=viviaya, createdTime=Tue Oct 03 17:58:43 CST 2023, time=2023-10-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1182993, encodeId=9a5711829937b, content=各位大神，这个杂志是收短的letter还是普通的article？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLavbJ2R1TmjvPODue2WrnIQnlfz5hB04sROM546B9oLHvY58gSm21nA1K8ZdK0icGmZoibic26aC33w/0, createdBy=500b2173298, createdName=ms776015483565643, createdTime=Mon Jan 10 22:35:29 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181961, encodeId=58a9118196150, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药理学 经验分享：很快，两天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c25584198, createdName=第五先生, createdTime=Fri Jan 07 19:57:39 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=)]

2021-02-21 ms2205852206988122

请问大家投稿过程大概花了多久啊？

115 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务